We are ViiV Healthcare – the only global pharma 100% dedicated to preventing, treating & curing HIV.
Unafraid to be first we bring together our transformational science and a deep understanding of the communities we serve – all to make HIV history.
25/09/2025
We are committed to championing community leaders like Sasha who are driving change in the HIV landscape for disproportionately impacted communities.
Watch to learn how Sasha’s team at Somos Familia is addressing HIV stigma and partnering with healthcare providers to improve outcomes for the Hispanic community. 💪
Content intended for US audiences only.
18/09/2025
Today on National HIV/AIDS and Aging Awareness Day, we continue to celebrate the resilience of everyone living with HIV, including Dandelions - individuals who acquired HIV at birth.
At , Princess caught up with Kalee who shared more about Dandelions along with her advice for others navigating aging with HIV.
Content intended for US audiences only.
16/09/2025
Did you know that over half of all people living with globally are women?
Women face unique challenges when it comes to HIV, from health considerations to pregnancy.
👉 Swipe through to learn more
27/08/2025
Did you know integrase strand transfer inhibitors (INSTIs) play a central role in modern care?
They’re at the core of our pipeline because they offer potency, long-term tolerability, and a high barrier to resistance.
Did you know HIV continues to disproportionately impact communities in the South due to complex factors like socioeconomic barriers, language challenges, and cultural norms?
This Southern HIV/AIDS Awareness Day, swipe to learn more about this impact and steps we’re taking to address this epidemic.
Content intended for US audiences only.
18/08/2025
Broadly neutralising antibodies (bNAbs) have the potential to transform the future of care. bNAbs offer dual action capabilities to inhibit virus transmission while targeting and eliminating HIV infected cells.
Imagine a future where HIV Treatment adapts to life-not the other way around.
Scientific innovation continues to open new doors in HIV Care, inspiring hope for more personalised and empowering approaches to treatment.
In partnership with CNN Create , we are exploring how research and progress are shaping tomorrow’s possibilities for people living with HIV
Find out more about in our bio ☝️🎥
Content by ViiV Healthcare
30/07/2025
From Tokyo to Toronto, wherever we are in the world, we take enormous in standing with the + community. Whether it’s our colleagues, or the people we serve.
25/07/2025
The future of HIV care is here, and it's being shaped by long-acting medicines. These innovations offer more than just efficacy; they provide a profound opportunity to enhance quality of life by directly addressing self-stigma. We're proud to shape this future of HIV care as we work to end the epidemic.
Content intended for US audiences only.
24/07/2025
We’re feeling energised after an action-packed week at in Kigali, Rwanda.
Be the first to know and let us send you an email when ViiV Healthcare posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
At ViiV Healthcare we do things differently. From our unique origins to our innovative medicines, we push the boundaries of what people think is possible in HIV treatment and care.
If you should know one thing about us, know this: we will not rest until we leave no person living with #HIV (PLHIV) behind. Until the 37 million PLHIV is down to zero, we will continue searching for new ways to limit the impact of HIV.[1]
Born out of a partnership between GSK and Pfizer in 2009, with Shionogi joining in 2012, at ViiV Healthcare we are determined to help end the HIV epidemic. Our one focused goal unites our 1100 employees located across over 20 countries, with their expertise in research, manufacturing, policy and more, all guided by our mission to be here until HIV isn’t.
Our current portfolio of 14 HIV treatments is our first step in fighting back against the disease. This is only the beginning as our research centre in Branford, Connecticut, the world’s only HIV-dedicated facility, is utterly focused on finding new innovative medicines to help improve the lives of PLHIV.
Also searching to find major breakthroughs against HIV is our industry-defining partnership with the HIV Cure Centre at the University of North Carolina. Part of a unique public-private collaboration ‘Qura Therapeutics’, we have been combining resources and expertise to accelerate novel breakthroughs and maximise the chance of finding a HIV cure.
Alongside our novel approach to R&D, improving access to medicines is just as important in delivering results for our patients.
At ViiV Healthcare we are dedicated to widening access to ensure those who need our medicines can receive them. Collaborations with organisations such as IAS, CHAI and MPP enable our medicines to make the greatest possible impact in countries around the world.
As an example, our voluntary licence agreements allow generic manufacturers to develop paediatric formulations of our medicines where 99% of children living with HIV live. We are committed to working ever closer with our partners through continued access initiatives.
To accelerate the eradication of HIV once and for all, we put significant focus on community initiatives to strengthen local healthcare services for PLHIV.
Through our Positive Action programmes which back over 300 projects worldwide, our work with local communities aim to deliver long-lasting impacts on groups such as women and children. We seek to enhance local expertise and resources that build towards global goals including the WHO 90-90-90 targets, as well as our own dedicated mission of leaving no person living with HIV behind.[2]
[1] Global Health Observatory (GHO) data – HIV/AIDs. Available from: https://www.who.int/gho/hiv/en/. Last accessed: February 2019
